PMV Pharmaceuticals (PMVP)
(Delayed Data from NSDQ)
$1.31 USD
+0.08 (6.50%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.30 -0.01 (-0.76%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, PMV Pharmaceuticals, Inc. has a market cap of $65.18M, which represents its share price of $1.23 multiplied by its outstanding shares number of 52.99M. As a small-cap company, PMVP's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PMVP 1.31 +0.08(6.50%)
Will PMVP be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PMVP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PMVP
Here's Why PMV Pharmaceuticals (PMVP) Looks Ripe for Bottom Fishing
PMVP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for PMVP
Is PMVP building bullish momentum? Crossed Above 200 Day Moving Average shows up after surging 6.5%
200 Day Moving Average Resistance appears for PMVP after 1.6% move
Promising Phase 2 Trial Results and Strategic Plans Support Buy Rating for PMV Pharmaceuticals
PMVP forms Stochastic Buy Signal on September 17
Orbimed Advisors LLC Adjusts Holdings in PMV Pharmaceuticals Inc